位于河北省會石家莊的華北制藥集團公司26日對外通報稱，認為美國紐約東區聯邦法院對維生素C反壟斷案做出一審判決有悖事實和公正，目前正在按照美方法律程序積極申請撤銷這項判決。
Shijiazhuang (CNS) -- A major Chinese drug maker said on Tuesday that it was appealing a massive fine for alleged price-fixing levied by a United States court.
North China Pharmaceutical Group Corp (NCPC), a major drug maker in north China's Hebei province, said the US court's ruling is both unfair and inappropriate. It is prepared to file a written appeal of the decision, NCPC said.
A federal court in Brooklyn ruled earlier this month that NCPC and its affiliate Hebei Welcome Pharmaceutical Co must pay $162 million in fines for colluding to raise prices for vitamin C exports to the US market.
Zhang Tingde, head of the law department at NCPC, said the company has never exported vitamin C to the United States, and the affiliate company's exports account for less than 20 percent of China's total drug exports.
China's Ministry of Commerce said last week it firmly supports law-abiding Chinese companies' right to actively protect their legal rights and interests.
位于河北省會石家莊的華北制藥集團公司26日對外通報稱，認為美國紐約東區聯邦法院對維生素C反壟斷案做出一審判決有悖事實和公正，目前正在按照美方法律程序積極申請撤銷這項判決。
Copyright ©1999-2011 Chinanews.com. All rights reserved.
Reproduction in whole or in part without permission is prohibited.
